Basic Information
RNALocate ID: RLID:11004259
RNA Symbol: hsa-miR-320b
Localization: Microvesicle
RNA Information
RNA Name: hsa-miR-320b
RNA ID: miRBase:MIMAT0005792
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 23771658
Tissue/Cell Line: Hepatoma cells
Method: Microarray|qRT-PCR
Description: In line with the difference in number of detectable miRNAs, the expression levels of these miRNAs also varied between MVs and cells. Statistical analysis of the 148 co-expressing miRNAs showed that 25 miRNAs were aberrantly elevated inMVs and 75 miRNAs were significantly elevated in cells with more than two folds change. Forty-eight miRNAs had the similar signal intensity in both groups (table 1). Data are collected from Table 1.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01002752 Cytoplasm Nasopharyngeal carcinoma cells 20498841
RLID:01002753 Cytoplasm Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01002754 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:01002755 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:01002756 Nucleus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01002757 Nucleus Nasopharyngeal carcinoma cells 20498841
RLID:11004252 Exosome Pooled sera 27278097
RLID:11004253 Exosome Breast cancer cell line (MCF-7) 20976003
RLID:11004254 Exosome Ovarian follicular fluid 22116803
RLID:11004255 Exosome Plasma 23663360
RLID:11004256 Exosome Colon cancer cell line (LIM1863) 25330373
RLID:11004257 Microvesicle Plasma 23077538
RLID:11004258 Microvesicle Seminal plasma 23539611
RLID:11004260 Microvesicle Serum 24797360
RLID-D:11000750 Microvesicle Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine
RLID-D:11001649 Exosome Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-320b Multiple sclerosis chronic progressive MNDR-E-MI-39356
MNDR hsa-miR-320b Oral squamous cell carcinoma MNDR-E-MI-39357
MNDR hsa-miR-320b High-grade serous ovarian carcinoma MNDR-E-MI-39358
MNDR hsa-miR-320b Estrogen-receptor positive breast cancer MNDR-E-MI-39359
MNDR hsa-miR-320b Estrogen-receptor negative breast cancer MNDR-E-MI-39360
MNDR hsa-miR-320b Progesterone-receptor positive breast cancer MNDR-E-MI-39361
MNDR hsa-miR-320b Progesterone-receptor negative breast cancer MNDR-E-MI-39362
MNDR hsa-miR-320b Her2-receptor positive breast cancer MNDR-E-MI-39363
MNDR hsa-miR-320b Prostate cancer MNDR-E-MI-39364
MNDR hsa-miR-320b Gastric cancer MNDR-E-MI-39365
MNDR hsa-miR-320b Alzheimer disease MNDR-E-MI-39366
MNDR hsa-miR-320b Intracranial aneurysm MNDR-E-MI-39367
MNDR hsa-miR-320b Huntington disease MNDR-E-MI-39368
MNDR hsa-miR-320b Chorea MNDR-E-MI-39369
MNDR hsa-miR-320b Cardiovascular disease MNDR-E-MI-39370
MNDR hsa-miR-320b Carotid stenosis MNDR-E-MI-39371
MNDR hsa-miR-320b Moyamoya disease MNDR-E-MI-39372
MNDR hsa-miR-320b Down syndrome MNDR-E-MI-39373
MNDR hsa-miR-320b Parkinson disease MNDR-E-MI-39374
MNDR hsa-miR-320b Breast cancer MNDR-E-MI-39375
MNDR hsa-miR-320b Pancreatic cancer MNDR-E-MI-39376
MNDR hsa-miR-320b Nephroblastoma MNDR-E-MI-39377
MNDR hsa-miR-320b Colon adenocarcinoma MNDR-E-MI-39378
MNDR hsa-miR-320b Multiple sclerosis relapsing-remitting MNDR-E-MI-39379
MNDR hsa-miR-320b Carcinoma ductal breast MNDR-E-MI-39380
MNDR hsa-miR-320b Glioblastoma MNDR-E-MI-39381
MNDR hsa-miR-320b Glioma MNDR-E-MI-39382
MNDR hsa-miR-320b Chronic obstructive pulmonary disease MNDR-E-MI-39383
MNDR hsa-miR-320b Amyotrophic lateral sclerosis MNDR-E-MI-39384
MNDR hsa-miR-320b Osteosarcoma MNDR-E-MI-39385
MNDR hsa-miR-320b Liver cancer MNDR-E-MI-39386
MNDR hsa-miR-320b Gastric adenocarcinoma MNDR-E-MI-39387
MNDR hsa-miR-320b Lung squamous cell carcinoma MNDR-E-MI-39388
MNDR hsa-miR-320b Lung adenocarcinoma MNDR-E-MI-39389
MNDR hsa-miR-320b Adrenocortical cancer MNDR-E-MI-39390
MNDR hsa-miR-320b Thyroid carcinoma MNDR-E-MI-39391
MNDR hsa-miR-320b Ovarian carcinoma MNDR-E-MI-39392
MNDR hsa-miR-320b Myasthenia gravis autoimmune experimental MNDR-E-MI-39393
MNDR hsa-miR-320b Carcinoma renal cell MNDR-E-MI-39394
MNDR hsa-miR-320b Kidney renal papillary cell carcinoma MNDR-E-MI-39395
MNDR hsa-miR-320b Renal clear cell carcinoma MNDR-E-MI-39396
MNDR hsa-miR-320b Cholangiocarcinoma MNDR-E-MI-39397
MNDR hsa-miR-320b Esophageal cancer MNDR-E-MI-39398
MNDR hsa-miR-320b Liver cirrhosis MNDR-E-MI-39399
MNDR hsa-miR-320b Head and neck squamous cell carcinoma MNDR-E-MI-39400
MNDR hsa-miR-320b Heart failure MNDR-E-MI-39401
MNDR hsa-miR-320b Fibromyalgia MNDR-E-MI-39402
MNDR hsa-miR-320b Progressive multifocal leukoencephalopathy MNDR-E-MI-39403
MNDR hsa-miR-320b Breast invasive carcinoma MNDR-E-MI-39404
MNDR hsa-miR-320b Hepatocellular carcinoma MNDR-E-MI-39405
MNDR hsa-miR-320b B-cell lymphoma MNDR-E-MI-39406
MNDR hsa-miR-320b Rheumatoid arthritis MNDR-E-MI-39407
MNDR hsa-miR-320b Neuromyelitis optica MNDR-E-MI-39408
MNDR hsa-miR-320b Skin cutaneous melanoma MNDR-E-MI-39409
MNDR hsa-miR-320b Skin melanoma MNDR-E-MI-39410
MNDR hsa-miR-320b Colorectal cancer MNDR-E-MI-39411
MNDR hsa-miR-320b Nasopharynx carcinoma MNDR-E-MI-39412
MNDR hsa-miR-320b Nasopharyngeal cancer MNDR-E-MI-39413
MNDR hsa-miR-320b Venous thromboembolism MNDR-E-MI-39414
MNDR hsa-miR-320b Chronic pain MNDR-E-MI-39415
MNDR hsa-miR-320b Stroke lacunar MNDR-E-MI-39416
MNDR hsa-miR-320b Breast cancer her3+ negative MNDR-E-MI-39417
MNDR hsa-miR-320b Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-39418
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ABHD13 Homo sapiens RR00025353
TOP